Third-party reimbursement for pharmacist instruction about antihemophilic factor.
The trial and evaluation of pharmacy education program to teach a 14-year-old hemophiliac to self-administer Factor VIII at home is described. The home therapy program realized a cost saving of $20,230 for this patient for the first year; school attendance increased 15%. The results of the trial were used to justify a professional fee from Blue Cross of Central Ohio for the pharmacist's educational services.
D000293:Adolescent; D054598:Blue Cross Blue Shield Insurance Plans; D005169:Factor VIII / Q000008:administration & dosage* / Q000627:therapeutic use; D005252:Fees, Pharmaceutical; D006467:Hemophilia A / Q000188:drug therapy; D006699:Home Care Services; D006801:Humans; D007356:Insurance, Pharmaceutical Services; D008297:Male; D009820:Ohio; D010353:Patient Education as Topic; D010595:Pharmacists; D012646:Self Administration
D005169:Factor VIII